NCT00784420View on ClinicalTrials.gov

Drug Interaction Study Between Raltegravir And UK-453,061

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Healthy Volunteers
Interventions
DRUG

UK-453,061

UK-453,061 1000 mg once daily for 10 days

DRUG

UK-453,061

UK-453,061 1000 mg once daily for 10 days

DRUG

Raltegravir

Raltegravir 400 mg twice daily for 10 days

DRUG

Raltegravir

Raltegravir 400 mg twice daily for 10 days

Trial Locations (1)

06511-5473

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY